Integrative cancer epidemiology-the next generation

Cancer Discovery

Volumn 2, Issue 12, 2012, Pages 1087-1090

  Spitz, Margaret R ^a   Caporaso, Neil E ^b   Sellers, Thomas A ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CARCINOGENESIS; DNA SEQUENCE; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPING TECHNIQUE; HEREDITY; HUMAN; TRANSLATIONAL RESEARCH;

HUMANS; MOLECULAR EPIDEMIOLOGY; NEOPLASMS;

EID: 84871515357     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-12-0424     Document Type: Article

References (28)

1. Greenwald P, Dunn BK. Landmarks in the history of cancer epidemiology. Cancer Res 2009; 69: 2151-62.
2. Taubes G. Epidemiology faces its limits. Science 1995; 269: 164-9.
3. Perera FP. Molecular cancer epidemiology: a new tool in cancer prevention. J Natl Cancer Inst 1987; 78: 887-98.
4. Sellers TA. The beginning of the end for the epidemiologic focus on gene-environment interactions? Cancer Epidemiol Biomarkers Prev 2006; 15: 1059-60.
5. Thun MJ, Hoover RN, Hunter DJ. Bigger, better, sooner-scaling up for success. Cancer Epidemiol Biomarkers Prev 2012; 21: 571-5.
6. Kuller LH. Invited commentary. The twenty-first century epidemiologist. A need for different training? Am J Epidemiol 2012; 176: 668-71.
7. Spitz MR, Wu X, Mills G. Integrative epidemiology: from risk assessment to outcome prediction. J Clin Oncol 2005; 23: 267-75.
8. Caporaso NE. Integrative study designs-next step in the evolution of molecular epidemiology. Cancer Epidemiol Biomarkers Prev 2007; 16: 365-6.
9. Ogino S, Stampfer M. Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology. J Natl Cancer Inst 2010; 102: 365-7.
10. Thomas D. Gene-environment-wide association studies: emerging approaches. Nat Rev Genet 2010; 11: 259-72.
11. Khoury MJ, Wacholder S. Invited commentary: from genome-wide association studies to gene-environment-wide interaction studies-challenges and opportunities. Am J Epidemiol 2009; 169: 227-30; discussion 234-5.
12. Patel CJ, Bhattacharya J, Butte AJ. An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus. PLoS ONE 2010; 5: e10746.
13. Snape K, Ruark E, Tarpey P, Renwick A, Turnbull C, Seal S, et al. Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer. Breast Cancer Res Treat 2012; 134: 429-33.
14. Yang XR, Ng D, Alcorta DA, Liebsch NJ, Sheridan E, Li S, et al. T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat Genet 2009; 41: 1176-8.
15. Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011; 12: 529-41.
16. Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A, Lau KW, et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 2012; 483: 570-5.
17. Platz EA, Yegnasubramanian S, Liu JO, Chong CR, Shim JS, Kenfield SA, et al. A novel two-stage transdisciplinary study indentifies digoxin as a possible drug for prostate cancer treatment. Cancer Discov 2011; 1: 68-77.
18. Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010; 11: 415-25
19. Kazma R, Bailey JN. Population-based and family-based designs to analyze rare variants in complex diseases. Genet Epidemiol 2011; 35 Suppl 1: S41-7.
20. Khoury MJ, Freedman AN, Gillanders EM, Harvey CE, Kaefer C, Reid BC, et al. Frontiers in cancer epidemiology: a challenge to the research community from the epidemiology and genomics research program at the national cancer institute. Cancer Epidemiol Biomarkers Prev 2012; 21: 999-1000.
21. Kelemen LE, Sellers TA, Vachon CM. Can genes for mammographic density inform cancer etiology? Nat Rev Cancer 2008; 8: 812-23.
22. Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, et al. Radiomics: the process and the challenges. J Magn Reson Imaging 2012; 30: 1234-48.
23. Sellers TA, Caporaso N, Lapidus S, Petersen GM, Trent J. Opportunities and barriers in the age of team science. Cancer Causes Control 2006; 17: 229-37.
24. Mechanic LE, Chen HS, Amos CI, Chatterjee N, Cox NJ, Divi RL, et al. Next generation analytic tools for large scale genetic epidemiology studies of complex diseases. Genet Epidemiol 2012; 36: 22-35.
25. Ogino S, King EE, Beck AH, Sherman ME, Milner DA, Giovannucci E. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am J Epidemiol 2012; 176: 659-67.
26. Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, et al. STROBE Statement. Strengthening the reporting of observational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. PLoS Med 2011; 8: e1001117.
27. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. PLoS Med 2011; 8: e1000420.
28. Khoury MJ, Gwinn M, Ioannidis JP. The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol 2010; 172: 517-24